ISSN 0975-3583
 

Journal of Cardiovascular Disease Research



    Assess the safety and efficacy of amitriptyline, pregabalin, and gabapentin for the management of neuropathic pain at Ayaan Institute of Medical Sciences


    Dr Kamal Hasan .K, Dr Gnana Deepthi Koppolu
    JCDR. 2024: 3276-3284

    Abstract

    Background: The most prevalent neuropathic pain disorders now being treated with tricyclic antidepressants (TCA), gabapentin, and pregabalin are considered first-line treatments for neuropathic pain. Many times, current neuropathic pain treatments are ineffective. Despite the availability of substantial information from numerous recommendations, there is still a significant degree of heterogeneity in treatment patterns. According to recent statistics from the Indian market, the guidelines actually advocate the use (selling) of medications including amitriptyline, pregabalin, and gabapentin.

    Description

    .

    » PDF

    Volume & Issue

    Volume 15 Issue 1

    Keywords